Campylobacter jejuni-related cardiomyopathy: Unknown entity or yet underreported?

Int J Cardiol. 2015 Nov 1:198:24-5. doi: 10.1016/j.ijcard.2015.06.110. Epub 2015 Jul 3.

Authors

Jerrold Spapen¹, Hadewich Hermans², Michael Rosseel³, Ian Buysschaert⁴

Affiliations

¹ Department of Internal Medicine, University Hospital, Vrije Universiteit, Brussels, Belgium.
² Department of Cardiology, Algemeen Stedelijk Ziekenhuis, Campus Geraardsbergen, Belgium.
³ Department of Cardiology, Algemeen Stedelijk Ziekenhuis, Campus Aalst, Belgium.
⁴ Department of Cardiology, Algemeen Stedelijk Ziekenhuis, Campus Aalst, Belgium. Electronic address: ianbuysschaert@hotmail.com.

PMID: 26149333
DOI: 10.1016/j.ijcard.2015.06.110

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aminoglycosides / therapeutic use
Anti-Infective Agents / therapeutic use
Campylobacter Infections / drug therapy
Campylobacter Infections / microbiology*
Campylobacter Infections / pathology*
Campylobacter jejuni / isolation & purification*
Carbapenems / therapeutic use
Echocardiography / methods
Enteritis / microbiology*
Enteritis / pathology
Fluoroquinolones / therapeutic use
Humans
Macrolides / therapeutic use
Male
Middle Aged
Myocarditis / diagnostic imaging
Myocarditis / drug therapy
Myocarditis / microbiology*

Substances

Aminoglycosides
Anti-Infective Agents
Carbapenems
Fluoroquinolones
Macrolides